Access cutting-edge bladder cancer treatment through this clinical trial at a research site in San Antonio. Study-provided care at no cost to qualified participants.
Access bladder cancer specialists in San Antonio at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bladder cancer treatment provided free
eRapa (encapsulated rapamycin) will be investigated for secondary prevention in patients with diagnosed non-muscle invasive bladder cancer (NMIBC) through a phase II double-blind randomized controlled trial of long-term (one year) prevention with eRapa versus placebo. The primary hypothesis is that eRapa decreases the risk of cancer relapse for patients with NMIBC. Secondary hypotheses are that eRapa can improve certain immune parameters and improve cognition and physical function without advers
Sponsor: Robert Svatek
Check if you qualify for this bladder cancer clinical trial in San Antonio, TX
If you're searching for bladder cancer treatment options in San Antonio, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Antonio research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.